Compare SHBI & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SHBI | YDES |
|---|---|---|
| Founded | 1876 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 676.5M | 543.0M |
| IPO Year | 1997 | N/A |
| Metric | SHBI | YDES |
|---|---|---|
| Price | $21.72 | $2.95 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.17 | N/A |
| AVG Volume (30 Days) | ★ 157.9K | 10.6K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.51% | N/A |
| EPS Growth | ★ 34.85 | N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | ★ $20,853,000.00 | N/A |
| Revenue This Year | $8.97 | N/A |
| Revenue Next Year | $6.26 | N/A |
| P/E Ratio | $41.92 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.35 | $2.88 |
| 52 Week High | $21.53 | $25.00 |
| Indicator | SHBI | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 68.31 | 26.98 |
| Support Level | $17.18 | $2.88 |
| Resistance Level | N/A | $5.36 |
| Average True Range (ATR) | 0.60 | 0.41 |
| MACD | 0.12 | -0.06 |
| Stochastic Oscillator | 91.13 | 3.74 |
Shore Bancshares Inc is a financial holding company based in the United States. Through its subsidiaries, it provides consumer and commercial banking products and services, as well as secondary mortgage lending, trust, wealth management, and financial planning services. The group caters to both business and individual clients, offering checking, savings, certificates of deposit, and overnight investment sweep accounts; commercial lending services, including secured and unsecured loans, working capital loans, lines of credit, etc; and safe deposit boxes, debit cards, telephone banking, and other financial products and services.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.